COVID-19, SARS-CoV-2, coronavirus, pandemic, antibodies, Iceland, qPCR, seroprevalence
COVID-19 Antibodies Last for at Least Four Months After Recovery
The results from a study in Iceland can’t say if a recovered patient’s antibodies can protect them from subsequent reinfection.
COVID-19 Antibodies Last for at Least Four Months After Recovery
COVID-19 Antibodies Last for at Least Four Months After Recovery

The results from a study in Iceland can’t say if a recovered patient’s antibodies can protect them from subsequent reinfection.

The results from a study in Iceland can’t say if a recovered patient’s antibodies can protect them from subsequent reinfection.

qPCR

COVID-19, SARS-CoV-2, pandemic, coronavirus, saliva, testing, PCR, FDA, emergency use authorization
FDA Approves New Saliva-Based COVID-19 Test
Amanda Heidt | Aug 17, 2020
SalivaDirect, an open-source protocol, avoids many of the supply bottlenecks of other tools and could be offered for as little as $10 a test.
COVID-19, coronavirus, SARS-CoV-2, pandemic, children, disease transmission, viral load, qPCR
Children Often Carry More Coronavirus than Adults Do: Study
Amanda Heidt | Jul 31, 2020
It’s not clear if their high viral load makes kids more likely to infect others.
Streamline qPCR for Better Data
Streamlining qPCR Through Standardization
The Scientist Creative Services Team, Bio-Rad Laboratories | May 4, 2022
The importance of standardization for research and diagnostic result reproducibility
COVID-19, SARS-CoV-2, pandemic, coronavirus, diagnostics, saliva, LAMP, PCR, clinical research, testing
Saliva Tests: How They Work and What They Bring to COVID-19
Amanda Heidt | Jul 9, 2020
Universities and healthcare facilities are planning to use spit tests to conduct large-scale screening.
Valerie Arboleda Uses Big Data to Unravel the Biology of a Rare Disease
Shawna Williams | May 1, 2018
The UCLA geneticist examines how defects in a histone protein lead to symptoms throughout the body.